Lord, Abbett & Co
AGN

Lord, Abbett & Co’s Allergan plc AGN Stock Holding History

Lord, Abbett & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-184,400
Closed -$31M – 749
2019
Q3 		$31M Sell
184,400
-15,504
-8% -$2.53M 0.11% 318
2019
Q2 		$33.5M Sell
199,904
-117,440
-37% -$16.3M 0.11% 320
2019
Q1 		$46.5M Buy
317,344
+42,562
+15% +$6.17M 0.15% 217
2018
Q4 		$36.7M Sell
274,782
-53,229
-16% -$8.73M 0.13% 242
2018
Q3 		$62.5M Buy
328,011
+178,392
+119% +$32.8M 0.17% 190
2018
Q2 		$24.9M Buy
149,619
+54,871
+58% +$8.81M 0.07% 419
2018
Q1 		$15.9M Sell
94,748
-97,638
-51% -$16.4M 0.05% 521
2017
Q4 		$31.5M Sell
192,386
-59,699
-24% -$10.7M 0.09% 354
2017
Q3 		$51.7M Buy
252,085
+89,122
+55% +$20.7M 0.15% 213
2017
Q2 		$39.6M Buy
+162,963
New +$38.3M 0.12% 273
2016
Q4 		– Sell
-194,603
Closed -$44.8M – 982
2016
Q3 		$44.8M Buy
194,603
+36,158
+23% +$8.84M 0.14% 238
2016
Q2 		$36.6M Buy
+158,445
New +$36.5M 0.11% 294
2015
Q4 		– Sell
-331,216
Closed -$90M – 983
2015
Q3 		$90M Sell
331,216
-87,723
-21% -$26.9M 0.27% 92
2015
Q2 		$127M Sell
418,939
-189,412
-31% -$56.5M 0.34% 58
2015
Q1 		$181M Sell
608,351
-221,378
-27% -$63.1M 0.46% 35
2014
Q4 		$214M Buy
829,729
+53,283
+7% +$13.3M 0.54% 32
2014
Q3 		$187M Sell
776,446
-587,770
-43% -$132M 0.47% 38
2014
Q2 		$304M Sell
1,364,216
-34,103
-2% -$7.06M 0.69% 8
2014
Q1 		$288M Sell
1,398,319
-826,410
-37% -$164M 0.66% 13
2013
Q4 		$374M Sell
2,224,729
-825,827
-27% -$129M 0.83% 7
2013
Q3 		$439M Sell
3,050,556
-541,348
-15% -$72.1M 1.01% 4
2013
Q2 		$453M Buy
+3,591,904
New +$407M 1.05% 4

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Lord, Abbett & Co's AGN Position: Q4 2019 in Review

Lord, Abbett & Co sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 184,400 shares — an estimated $31M sold.

Lord, Abbett & Co first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $453M in Q2 2013. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Lord, Abbett & Co reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 184,400 Allergan plc shares in Q4 2019, an estimated $31M.
  • Lord, Abbett & Co first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
  • Lord, Abbett & Co's Allergan plc position peaked at $453M in Q2 2013.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Lord, Abbett & Co's 13F filing for Q4 2019, filed 14 Feb 2020.